Biotechnology
| Sat 04 Jul 2026
Beijing, July 4 -- Edigene Beijing Biotechnology Co Ltd has submitted a patent application for Engineered T Cell with Prolonged Half-life in Vivo and Preparation Method Thereof. This invention was developed by Zhang Haixia, Zhang Yunyi, Fu Jianqiang, Yuan Pengfei, Yang Zhonghan, Liang Feifei, Sun Yu, Yi Yuting, Wu Lanlan and Lu ..